Streetbeat News

LOVFF

Cannara Biotech Inc

CEO

Zohar Krivorot

Industry

Medicinal and Botanical Manufacturing

Open

0.58

Mkt cap

43M

Volume

High

0.59

P/E Ratio

9.56

52-wk high

0.78

Low

0.48

Div yield

N/A

52-wk low

0.39

Cannara Biotech Inc. will host an investor webcast on December 19, 2024, to present its business operations and future plans. The company is a major cannabis producer with large facilities in Quebec.

Portfolio Pulse from

December 12, 2024 | 2:45 pm

Microsoft shares rise as the company reports better-than-expected Q1 2025 GAAP EPS and sales.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 8:05 pm

Canada's cannabis market is experiencing stagnation with nearly zero growth in 2024. Top producers like Village Farms, Tilray, Organigram, and Cronos are seeing shifts in market share. The flower segment remains crucial, while pre-rolls and vapes gain popularity. Companies are focusing on international expansion due to domestic market limitations.

Portfolio Pulse from Nicolás Jose Rodriguez

October 29, 2024 | 1:29 pm

Banzai has been granted an extension by the Nasdaq Hearing Panel to regain compliance with listing requirements.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 12:34 pm

Cannara Biotech Inc. reported a 6% YoY drop in Q3 gross profit but a 22% revenue increase, driven by enhanced sales force and infrastructure. The company saw net revenues of CA$19.5 million and a net income of CA$2 million. Operational highlights include expansion in Manitoba and the East Coast recreational market.

Portfolio Pulse from Jelena Martinovic

July 23, 2024 | 6:06 pm

The Canadian recreational cannabis market is experiencing a slowdown, with a mere 2% YoY growth in Q1 2024. However, some companies like Village Farms International, Organigram Holdings, and Cronos Group have shown significant sales growth, while others like Tilray Brands and Canopy Growth Corporation have faced declines.

Portfolio Pulse from Nicolás Jose Rodriguez

June 03, 2024 | 9:01 pm

Cannara Biotech Inc. reported a 51% YoY revenue increase in Q2 2024, with a wider net loss. The company saw a 68% revenue increase for the first half of fiscal 2024, highlighting its growing influence in the Canadian cannabis market. Despite the revenue growth, the company's net loss widened, but it maintained a positive adjusted EBITDA for the twelfth consecutive quarter. Cannara aims to become a leader in the global cannabis market.

Portfolio Pulse from Jelena Martinovic

May 01, 2024 | 7:45 pm

The cannabis sector experienced mixed performance on August 21, 2023, with several stocks seeing significant gains, while others suffered losses. Notable gainers include Radient Technologies (OTC:RDDTF), Trees (OTC:CANN), and 1933 Industries (OTC:TGIFF), while Red White & Bloom Brands (OTC:RWBYF), CBD Of Denver (OTC:CBDD), and Tetra Bio Pharma (OTC:TBPMF) were among the biggest losers.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 9:30 pm

The article lists the cannabis stocks that gained and lost on August 10, 2023. The biggest gainers were Choom Holdings (OTC:CHOOF), Item 9 Labs (OTC:INLB), and Delivra Health Brands (OTC:DHBUF), while the biggest losers were CannTrust Holdings (OTC:CNTTQ), SciSparc (NASDAQ:SPRC), and Khiron Life Sciences (OTC:KHRNF).

Portfolio Pulse from Benzinga Insights

August 10, 2023 | 9:30 pm

The article lists the cannabis stocks that gained and lost on August 4, 2023. The biggest gainers were EVIO, MJ Holdings, Khiron Life Sciences, Tetra Bio Pharma, and Maple Leaf Green World. The biggest losers were Hemp, 1606, Indiva, Panacea Life Sciences, and Earth Science Tech.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 9:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.